Mabwell (Shanghai) Bioscience Co., Ltd.(XSSC:688062) added to S&P Global BMI Index
Mabwell (Shanghai) Bioscience Co., Ltd.
Equities
688062
CNE100005RD2
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.62 CNY | -2.21% | -3.67% | +2.84% |
May. 07 | Mabwell Announces FDA Grants Orphan Drug Designation to 9MW2821 | CI |
Apr. 29 | Mabwell Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.84% | 1.86B | |
+7.34% | 113B | |
+11.08% | 106B | |
+0.41% | 22.27B | |
-11.84% | 22.22B | |
-5.99% | 19.43B | |
-37.85% | 17.87B | |
-6.01% | 17.24B | |
+7.03% | 14.29B | |
+35.38% | 12.52B |
- Stock Market
- Equities
- 688062 Stock
- News Mabwell (Shanghai) Bioscience Co., Ltd.
- Mabwell Bioscience Co., Ltd.(XSSC: 688062) added to S&P Global BMI Index